Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Scheper

Showing results (181-190 of 285) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|June 27, 2002
Increased expression of beta 2-microglobulin in multidrug-resistant tumour cellsG L Scheffer, M C de Jong, A Monks, et al.
Leukemia|July 1, 1997
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemiaM L Den Boer, C M Zwaan, R Pieters, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapyW S Dalton, T M Grogan, P S Meltzer, et al.
Scandinavian Journal of Gastroenterology|November 1, 1995
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controlsG Bouma, M Oudkerk Pool, J G Scharenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42E Moran, I Cleary, A M Larkin, et al.
International Journal of Cancer|October 23, 1997
Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodiesM J Flens, G L Scheffer, P van der Valk, et al.
British Journal of Cancer|September 25, 1999
Potent interaction of flavopiridol with MRP1J H Hooijberg, H J Broxterman, G L Scheffer, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance doseP A Palmer, J G Scharenberg, B M von Blomberg, et al.
Scandinavian Journal of Rheumatology|August 31, 2013
Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patientsJ W van der Heijden, Y G Assaraf, A H Gerards, et al.
Pageof 29

Showing results (181-190 of 285) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|June 27, 2002
Increased expression of beta 2-microglobulin in multidrug-resistant tumour cellsG L Scheffer, M C de Jong, A Monks, et al.
Leukemia|July 1, 1997
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemiaM L Den Boer, C M Zwaan, R Pieters, et al.
International Journal of Cancer|September 15, 1989
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude miceJ J Quak, A J Balm, J G Brakkee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapyW S Dalton, T M Grogan, P S Meltzer, et al.
Scandinavian Journal of Gastroenterology|November 1, 1995
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controlsG Bouma, M Oudkerk Pool, J G Scharenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42E Moran, I Cleary, A M Larkin, et al.
International Journal of Cancer|October 23, 1997
Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodiesM J Flens, G L Scheffer, P van der Valk, et al.
British Journal of Cancer|September 25, 1999
Potent interaction of flavopiridol with MRP1J H Hooijberg, H J Broxterman, G L Scheffer, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1994
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance doseP A Palmer, J G Scharenberg, B M von Blomberg, et al.
Scandinavian Journal of Rheumatology|August 31, 2013
Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patientsJ W van der Heijden, Y G Assaraf, A H Gerards, et al.
Pageof 29